Cargando…
Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
BACKGROUND: Intensity-modulated radiotherapy (IMRT) improves dose homogeneity and late toxicity compared to simple tangential techniques in adjuvant whole-breast radiotherapy for patients with breast cancer. Simultaneous-integrated boost (SIB) radiotherapy shortens the overall treatment time and imp...
Autores principales: | Krug, David, Köder, Christine, Häfner, Matthias F., Arians, Nathalie, Harrabi, Semi B., Koerber, Stefan A., Forster, Tobias, Schlampp, Ingmar, Sohn, Christof, Heil, Joerg, Hof, Holger, Hörner-Rieber, Juliane, Debus, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557053/ https://www.ncbi.nlm.nih.gov/pubmed/33050920 http://dx.doi.org/10.1186/s13014-020-01652-x |
Ejemplares similares
-
Methods of Esthetic Assessment after Adjuvant Whole-Breast Radiotherapy in Breast Cancer Patients: Evaluation of the BCCT.core Software and Patients’ and Physicians’ Assessment from the Randomized IMRT-MC2 Trial
por: Forster, Tobias, et al.
Publicado: (2022) -
Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients—First Clinical Results From a Single Center
por: König, Laila, et al.
Publicado: (2019) -
Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands
por: Schmid, Maximilian P., et al.
Publicado: (2021) -
Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)
por: Forster, Tobias, et al.
Publicado: (2020) -
Simultaneous integrated boost for adjuvant treatment of breast cancer- intensity modulated vs. conventional radiotherapy: The IMRT-MC2 trial
por: Askoxylakis, Vasileios, et al.
Publicado: (2011)